NCT03051958
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Karolinska Institutet Stockholm, Sweden
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,767 public trials
650 recruiting studies
Hypersensitivity trial results
NCT02308501
- Conditions
- Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
- Locations
-
Not specified
NCT01541423
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- Universitair Ziekenhuis Antwerpen (UZA) Antwerp, Edegem, Belgium
- Clinic St-Luc University Hospital Brussels, Belgium
- CHU d'Angers Angers, France
- Hôpital Claude-Huriez Lille, France
NCT04270552
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +8 more
- Locations
-
- Department of Pulmonary Diseases and Children Rheumatology, Medical University of Lublin Lublin, Poland
NCT04803617
- Conditions
- Geriatric, Hemic and Lymphatic Diseases, Hypersensitivity, +12 more
- Locations
-
- Giresun University Giresun, Turkey (Türkiye)
NCT01653756
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Investigational Site Berlin, Germany
- Investigational Site Großhansdorf, Germany
- Investigational Site Wiesbaden, Germany
- Investigational Site Harrow, United Kingdom
Completed
Safety of LAIV4 in Children With Asthma
NCT03600428
- Conditions
- Asthma, Asthma in Children, Bronchial Diseases, +21 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT03290898
- Conditions
- Asthma, Behavior, Bronchial Diseases, +8 more
- Locations
-
- Respiratory Research Unit, Birpebjerg Hospital Copenhagen NV, Denmark
NCT01761630
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
Completed
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
NCT03496974
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Florida Academic Centers Research & Education Coral Gables, Florida, United States